BAGUERA® C IDE Studies

Spineart is proud to partner with Dr. Hyun Bae at the Spine Institute, Santa Monica, California as part of two clinical trials evaluating BAGUERA® C, a new cervical disc replacement option for patients with degenerative cervical disc disease.

The clinical trials are evaluating the BAGUERA® C cervical artificial disc, which is designed to help maintain the natural behavior and mobility of a functional cervical spine.

Unlike spinal disc fusion, a common surgical treatment option, the goal of cervical disc replacement is to help preserve motion of the cervical spine or spinal segment after surgery. This can provide patients with improved quality of life after treatment.

Click here if you want to find out if you are a candidate: /us/ide-clinical-investigation/

Want to find a clinical study site near you or learn more information about the two studies? Go to /us/ide-clinical-investigation/

Investigational device limited by United States law to investigational use in the United States.

Related

Related items
Date - Category Illustration Title Excerpt
  • Corporativo
26 September 2025 Plan-Les-Ouates & Zurich (CH) – Antwerp (BE) Spineart (www.spineart.com), a global medtech innovator in advanced spine surgery solutions, today announces a CHF 25 million capital increase backed...
  • Productos
Spineart announces the full-market launch of its SCARLET® AC-Ti secured anterior cervical cage in the United States. Following 510(k) clearance in May 2024, SCARLET® AC-Ti has been extensively evaluated by...
  • BAGUERA® C
Spineart today announces that it has completed a planned interim analysis for its 2-level BAGUERA® C IDE study, which showed that BAGUERA® C, its innovative cervical disc prosthesis, met the...